Difference between revisions of "Team:CPU CHINA"

Revision as of 02:01, 18 October 2018 (view source)

Ser Archer (Talk | contribs)

← Older edit

Revision as of 02:04, 18 October 2018 (view source)

Ser Archer (Talk | contribs)

Newer edit →

Line 120:

A gene therapy strategy to traget hepatocellular carcinoma based on conditional RNA interference

</div> -->

−

~~<h1 style="position:absolute;width:90%;margin-left:5%;top:16%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1>~~

+

Line 139:

</div>

−

MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.

+

<h1 style="position:absolute;width:90%;margin-left:5%;top:16%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1>

+

<h4>MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.</h4>

</div>

@@ Line 120: / Line 120: @@
 A gene therapy strategy to traget hepatocellular carcinoma based on conditional RNA interference
 </div> -->
-<h1 style="position:absolute;width:90%;margin-left:5%;top:16%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1>
 <!-- *****************************************马车动画*********************************************-->
 <video id="home-video" style="position:absolute;width:90%;margin-left:5%;top:11%;z-index:100;display:none;" controls="controls" loop="false" preload="preload">
@@ Line 139: / Line 139: @@
 </div>
 <div id="words" style="position:relative;display:none;width:80%;top:69%;margin-left:10%;font-size:2.5rem;line-height:2.5;">
-   MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.
+<h1 style="position:absolute;width:90%;margin-left:5%;top:16%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1>
+   <h4>MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application.</h4>
 </div>